FLGT
Fulgent Genetics Inc
NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$20.45
+1.64% today
Updated 2026-09-11
Market cap
$539.02M
P/E ratio
—
P/S ratio
1.66x
EPS (TTM)
$-2.83
Dividend yield
—
52W range
$13 – $31
Volume
0.3M
Fulgent Genetics Inc (FLGT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$20.45
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$51.10
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $0.6B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -5.21% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -26.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.